Medpace Holdings

Traded on the St. Petersburg Stock Exchange
Medpace Holdings, Inc. provides services for Phase I-IV of drug and medical device development services including regulatory services and central laboratory services.
Medpace Holdings stock price chart
vol.
change
P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Medpace Holdings balance sheet

Report period2018 2019 2020 2021 2022 Q2 23
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Medpace Holdings cash flows

Report period2018 2019 2020 2021 2022 Q2 23 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
Adjusted Earnings
EBITDA
Adjusted EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS
Adjusted EPS

Medpace Holdings multipliers

Report period2018 2019 2020 2021 2022 Q2 23 TTM
P/E
P/E adj.
E/P
E adj./P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
Net Debt/EBITDA adj.
EV/EBITDA
EV/EBITDA adj.

Medpace Holdings profitability

Report period2018 2019 2020 2021 2022 Q2 23 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Medpace Holdings assets
Medpace Holdings cash flows

Medpace Holdings shares

TickerNameTypeNominal valueISINPrice
MEDP:USMedpace Holdings, Inc.Common share-US58506Q1094$390.9
Medpace Holdings news
26.04.2022
Medpace Holdings' GAAP net income for 3 months of 2022 was $61.311 million, up 41.6% from $43.306 million in the previous year. Revenue increased 27.3% to $330.947 million compared to $259.965 million a year earlier.
15.02.2022
Medpace Holdings' GAAP net income for 2021 was $181.848 million, up 25.1% from $145.384 million in the previous year. Revenues increased 23.3% to $1.142 billion from $0.926 billion a year earlier.
26.10.2021
Medpace Holdings' GAAP net income for 9M 2021 was $131.814 million, an increase of 39.5% compared to $94.518 million in the previous year. Revenue increased 25.2% to $833.825 million from $666.247 million a year earlier.
27.07.2021
Medpace Holdings' GAAP net income for the six months of 2021 was $83.24 million, up 56.9% from $53.058 million in the previous year. Revenue increased 23.5% to $538.258 million from $435.874 million a year earlier.
General information
Company nameMedpace Holdings
SectorHealth Care / Health Care Equipment & Services / Health Care Providers & Services / Health Care Services
Business address5375 MEDPACE WAY CINCINNATI OH 45227 (513) 579-9911
Mailing address5375 MEDPACE WAY CINCINNATI OH 45227
Websitewww.medpace.com
Information disclosurewww.sec.gov